Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Bio Techne's Business Segments
Bio Techne's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q3 FY2026
Reportable Segments
2
Largest Segment
Protein Sciences
Total Revenue
$ 311
Regions Reported
3
Revenue Share by Reportable Segment - Q3 FY2026
- Protein Sciences72.7%
- Diagnostics and Spatial Biology27.5%
Revenue by Reportable Segment - Q3 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Protein Sciences | $ 226 | 72.7% |
| Diagnostics and Spatial Biology | $ 86 | 27.5% |
Revenue Share by Region - Q3 FY2026
- EMEA Excluding UK23.6%
- APAC excluding Greater China7%
- Rest of World2.5%
Revenue by Geographic Region - Q3 FY2026
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| EMEA Excluding UK | $ 73 | 23.6% |
| APAC excluding Greater China | $ 22 | 7% |
| Rest of World | $ 8 | 2.5% |
Revenue by Product & Service Category - Q3 FY2026
- Product and Services98.4%
- Consumables82.7%
- Instruments8.9%
- Service6.9%
- Royalty1.6%
Revenue by Product & Service Category - Q3 FY2026
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Product and Services | $ 306 | 98.4% |
| Consumables | $ 257 | 82.7% |
| Instruments | $ 28 | 8.9% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
2 more categories available
Sign in to unlock the full Bio Techne dataset.
Description of Bio Techne
Bio-Techne Corporation is a global life sciences company whose mission is to provide innovative, high-quality scientific tools and resources to researchers in diagnostics and therapeutics.
The company was founded in 1976 and is headquartered in Minneapolis, Minnesota.
Bio-Techne operates through four divisions: Protein Platforms, Diagnostics & Genomics, Cell & Gene Therapy, and Clinical Controls.
The Protein Platforms division provides innovative protein analysis tools and technologies to researchers in academic and biopharmaceutical industries.
This includes single-cell proteomics, mass spectrometry, and western blotting among others.
The Diagnostics & Genomics division offers diagnostic kits and reagents for clinical and research markets, including ELISAs, cell culture products, and RNA analysis tools.
The Cell & Gene Therapy division provides innovative solutions for the development and production of cell and gene therapies.
This includes T cell activation reagents, gene editing tools, and viral vector systems among others.
The Clinical Controls division specializes in the production of quality controls and calibrators for clinical laboratories.
These products are used for monitoring the accuracy and precision of laboratory testing procedures.
Bio-Techne operates globally and serves a diverse customer base including biopharmaceutical companies, academic and government institutions, clinical research organizations, and diagnostic laboratories.
The company's dedication to research and development, customer support, and quality control has earned it a reputation of excellence in the life sciences industry.
Bio-Techne has over 3,000 employees worldwide and is committed to advancing science by providing innovative solutions and technologies for researchers and clinicians alike.
The company was founded in 1976 and is headquartered in Minneapolis, Minnesota.
Bio-Techne operates through four divisions: Protein Platforms, Diagnostics & Genomics, Cell & Gene Therapy, and Clinical Controls.
The Protein Platforms division provides innovative protein analysis tools and technologies to researchers in academic and biopharmaceutical industries.
This includes single-cell proteomics, mass spectrometry, and western blotting among others.
The Diagnostics & Genomics division offers diagnostic kits and reagents for clinical and research markets, including ELISAs, cell culture products, and RNA analysis tools.
The Cell & Gene Therapy division provides innovative solutions for the development and production of cell and gene therapies.
This includes T cell activation reagents, gene editing tools, and viral vector systems among others.
The Clinical Controls division specializes in the production of quality controls and calibrators for clinical laboratories.
These products are used for monitoring the accuracy and precision of laboratory testing procedures.
Bio-Techne operates globally and serves a diverse customer base including biopharmaceutical companies, academic and government institutions, clinical research organizations, and diagnostic laboratories.
The company's dedication to research and development, customer support, and quality control has earned it a reputation of excellence in the life sciences industry.
Bio-Techne has over 3,000 employees worldwide and is committed to advancing science by providing innovative solutions and technologies for researchers and clinicians alike.
Bio-Techne Corporation is a prominent global life sciences company, recognized for its extensive array of innovative solutions tailored to meet the needs of customers across various sectors, including academic research, clinical laboratories, and pharmaceutical companies. Below is a comprehensive overview of the key segments, products, and services offered by Bio-Techne:
1. Diagnostics and Genomics Segment:
This segment is pivotal in providing tools that facilitate the detection and analysis of genetic and molecular data, crucial for diagnostic purposes.
- Assays and Kits: Bio-Techne offers a wide range of assays and kits designed to analyze gene expression, RNA splicing, and more. These products leverage advanced methodologies to yield reliable data for both clinical and research settings.
- Reagents: The company supplies high-quality reagents that are essential in conducting molecular biology experiments. These reagents ensure accuracy and reproducibility in various applications.
- Real-Time PCR Solutions: Bio-Techne provides reagents and kits specific for quantitative PCR (qPCR), which is fundamental in gene expression analysis and other genomic applications.
- Nucleic Acid Purification: Products designed for the extraction and purification of DNA and RNA, critical for downstream applications such as sequencing and cloning.
- Bioinformatics Tools: The segment also includes software and analytical tools that aid in interpreting genomic data, helping researchers to make informed decisions based on complex data sets.
Protein Sciences Segment:
Bio-Technes Protein Sciences segment is well-established, providing essential products for protein research and validation.
- Antibodies: The company boasts an extensive portfolio of antibodies validated for a myriad of applications, including Western blotting, immunohistochemistry, and ELISA. These antibodies facilitate research into protein function and expression, paving the way for advancements in diagnostics and therapies.
- Immunoassays: Bio-Techne develops robust immunoassays that are utilized for the quantitative measurement of proteins, offering essential tools in both clinical diagnostics and research.
- Proteins: The company provides recombinant proteins that serve as important standards and reagents in various experimental settings. These proteins cover a diverse range of biological functions.
- RNA Interference (RNAi): The segment includes RNAi products designed for gene silencing, enabling researchers to study gene function and regulation.
Cell and Gene Therapy Segment:
Bio-Techne is at the forefront of supporting new therapeutics through its offerings in this rapidly evolving field.
- Bioactive Molecules: The segment offers an array of bioactive molecules such as cytokines and growth factors, which are critical in the development of cell-based therapies.
- Cell Culture Media: Customized media formulations are available to support the proliferation and maintenance of various cell types used in therapeutic contexts.
- Gene Editing Tools: Bio-Techne provides innovative tools and technologies that assist in precise genome editing, facilitating research and development initiatives aimed at curing genetic disorders.
Clinical Controls Segment:
This segment plays a crucial role in ensuring the reliability and accuracy of diagnostic tests.
- Quality Control Materials: Bio-Techne supplies controls that are essential for validating the performance of in vitro diagnostic devices. This ensures that diagnostic results are trustworthy and pivotal for patient management.
- Proficiency Testing: The segment may also encompass services related to proficiency testing, helping laboratories maintain compliance with regulatory standards.
Custom Services Segment:
Bio-Techne recognizes the unique needs of its customers and offers bespoke solutions through this segment.
- Custom Assay Development: Expertise in developing tailor-made assays that fit specific research needs, providing researchers with tools that are uniquely suited to their experiments.
- Protein Expression and Purification: The company offers services for optimized protein expression and purification, catering to the diverse requirements of their clientele.
- Oligonucleotide Synthesis: Custom oligonucleotide synthesis services allow researchers to acquire tailored DNA or RNA sequences for their specific applications.
Conclusion:
Bio-Techne Corporation embodies a dedication to advancing scientific research and breakthroughs in human health through its vast array of innovative solutions. By focusing on diagnostic capabilities, protein and genomic sciences, therapeutic development, quality control measures, and custom services, the company plays a significant role in empowering researchers and clinicians alike. This commitment to innovation and customer satisfaction positions Bio-Techne as a leader in the life sciences industry, making a meaningful impact on research and patient care worldwide.
1. Diagnostics and Genomics Segment:
This segment is pivotal in providing tools that facilitate the detection and analysis of genetic and molecular data, crucial for diagnostic purposes.
- Assays and Kits: Bio-Techne offers a wide range of assays and kits designed to analyze gene expression, RNA splicing, and more. These products leverage advanced methodologies to yield reliable data for both clinical and research settings.
- Reagents: The company supplies high-quality reagents that are essential in conducting molecular biology experiments. These reagents ensure accuracy and reproducibility in various applications.
- Real-Time PCR Solutions: Bio-Techne provides reagents and kits specific for quantitative PCR (qPCR), which is fundamental in gene expression analysis and other genomic applications.
- Nucleic Acid Purification: Products designed for the extraction and purification of DNA and RNA, critical for downstream applications such as sequencing and cloning.
- Bioinformatics Tools: The segment also includes software and analytical tools that aid in interpreting genomic data, helping researchers to make informed decisions based on complex data sets.
Protein Sciences Segment:
Bio-Technes Protein Sciences segment is well-established, providing essential products for protein research and validation.
- Antibodies: The company boasts an extensive portfolio of antibodies validated for a myriad of applications, including Western blotting, immunohistochemistry, and ELISA. These antibodies facilitate research into protein function and expression, paving the way for advancements in diagnostics and therapies.
- Immunoassays: Bio-Techne develops robust immunoassays that are utilized for the quantitative measurement of proteins, offering essential tools in both clinical diagnostics and research.
- Proteins: The company provides recombinant proteins that serve as important standards and reagents in various experimental settings. These proteins cover a diverse range of biological functions.
- RNA Interference (RNAi): The segment includes RNAi products designed for gene silencing, enabling researchers to study gene function and regulation.
Cell and Gene Therapy Segment:
Bio-Techne is at the forefront of supporting new therapeutics through its offerings in this rapidly evolving field.
- Bioactive Molecules: The segment offers an array of bioactive molecules such as cytokines and growth factors, which are critical in the development of cell-based therapies.
- Cell Culture Media: Customized media formulations are available to support the proliferation and maintenance of various cell types used in therapeutic contexts.
- Gene Editing Tools: Bio-Techne provides innovative tools and technologies that assist in precise genome editing, facilitating research and development initiatives aimed at curing genetic disorders.
Clinical Controls Segment:
This segment plays a crucial role in ensuring the reliability and accuracy of diagnostic tests.
- Quality Control Materials: Bio-Techne supplies controls that are essential for validating the performance of in vitro diagnostic devices. This ensures that diagnostic results are trustworthy and pivotal for patient management.
- Proficiency Testing: The segment may also encompass services related to proficiency testing, helping laboratories maintain compliance with regulatory standards.
Custom Services Segment:
Bio-Techne recognizes the unique needs of its customers and offers bespoke solutions through this segment.
- Custom Assay Development: Expertise in developing tailor-made assays that fit specific research needs, providing researchers with tools that are uniquely suited to their experiments.
- Protein Expression and Purification: The company offers services for optimized protein expression and purification, catering to the diverse requirements of their clientele.
- Oligonucleotide Synthesis: Custom oligonucleotide synthesis services allow researchers to acquire tailored DNA or RNA sequences for their specific applications.
Conclusion:
Bio-Techne Corporation embodies a dedication to advancing scientific research and breakthroughs in human health through its vast array of innovative solutions. By focusing on diagnostic capabilities, protein and genomic sciences, therapeutic development, quality control measures, and custom services, the company plays a significant role in empowering researchers and clinicians alike. This commitment to innovation and customer satisfaction positions Bio-Techne as a leader in the life sciences industry, making a meaningful impact on research and patient care worldwide.